iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
1.950
+0.630 (47.73%)
At close: Sep 12, 2025, 4:00 PM EDT
1.910
-0.040 (-2.06%)
After-hours: Sep 12, 2025, 7:59 PM EDT
iSpecimen Market Cap
iSpecimen has a market cap or net worth of $10.80 million as of September 12, 2025. Its market cap has increased by 184.40% in one year.
Market Cap
10.80M
Enterprise Value
10.50M
1-Year Change
184.40%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since the IPO on June 17, 2021, iSpecimen's market cap has decreased from $50.15M to $10.80M, a decrease of -78.46%. That is a compound annual growth rate of -30.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 10.80M | 322.64% |
| Dec 31, 2024 | 2.56M | -43.75% |
| Dec 29, 2023 | 4.54M | -62.95% |
| Dec 30, 2022 | 12.26M | -81.98% |
| Dec 31, 2021 | 68.07M | 35.75% |
| Jun 17, 2021 | 50.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |